Global marketsUpdated Yesterday

FT questions CVS’s M&A-first strategy as stock underperforms

The Financial Times uses CVS’s breakup to question whether an M&A-first strategy is the healthiest option. CVS has touted better customer outcomes and major financial benefits, but the FT says its stock price has underperformed. The company’s stated gains and its stock performance make an awkward contrast.

1 publisher1 report

Coverage started Yesterday